Arroyo Ian 4
4 · Freightos Ltd · Filed Apr 20, 2026
Research Summary
AI-generated summary of this filing
Freightos (CRGO) CSO Ian Arroyo Sells 1,751 Shares
What Happened
- Ian Arroyo, Chief Strategy Officer of Freightos Ltd (CRGO), disposed of a total of 1,751 ordinary shares on April 16, 2026. The sales were two transactions: 756 shares at $1.85 ($1,399) and 995 shares at $1.85 ($1,841), totaling approximately $3,240.
- These were sales (S) and the filing identifies them as sale-to-cover transactions related to restricted stock units (RSUs), a routine tax-withholding step when RSUs vest rather than a directional bet on the stock.
Key Details
- Transaction date: April 16, 2026; Price: $1.85 per share for both sales.
- Shares sold: 756 and 995 (total 1,751); Proceeds: about $1,399 and $1,841 (total ≈ $3,240).
- Purpose: Reported as sale-to-cover to satisfy tax liability upon RSU vesting (footnote F1).
- Related RSU notes: Filing includes multiple RSU grant vesting schedules (e.g., grants that began vesting Oct 15, 2025 and Apr 1, 2026 — see footnotes F2–F10 for schedules).
- Holdings after the transactions: Not specified in the provided excerpt of the filing.
- Filing timeliness: Form 4 was filed Apr 20, 2026 for Apr 16 transactions (filed within the required two business days).
Context
- Sale-to-cover transactions are common when RSUs vest: the company or broker sells a portion of shares to cover taxes rather than representing a voluntary sell decision by the insider. Such transactions are generally considered routine and do not necessarily indicate the insider's view on the company's prospects.
Insider Transaction Report
Form 4
Freightos LtdCRGO
Arroyo Ian
Chief Strategy Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-16$1.85/sh−756$1,399→ 6,244 total - Sale
Ordinary Shares
[F1][F3]2026-04-16$1.85/sh−995$1,841→ 20,505 total
Holdings
- 21,141
Ordinary Shares
[F4] - 37,500
Ordinary Shares
[F4][F5] - 37,500
Ordinary Shares
[F4][F6] - 36,000
Ordinary Shares
[F4][F7] - 38,000
Ordinary Shares
[F4][F8] - 38,000
Ordinary Shares
[F4][F9] - 54,600
Ordinary Shares
[F4][F10] - 49,473
Stock Option (right to buy)
[F4]Exercise: $1.07From: 2024-12-01Exp: 2030-12-16→ Ordinary Shares (49,473 underlying) - 12,314
Stock Option (right to buy)
[F4]Exercise: $4.17From: 2025-07-01Exp: 2031-07-19→ Ordinary Shares (12,314 underlying) - 228,674
Stock Option (right to buy)
[F4]Exercise: $4.17From: 2026-01-01Exp: 2032-02-17→ Ordinary Shares (228,674 underlying)
Footnotes (10)
- [F1]The transaction reported in this row consists of a sale-to-cover (to cover tax liability) on behalf of the Reporting Person of ordinary shares received upon vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
- [F10]The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
- [F2]The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026.
- [F3]The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027.
- [F4]There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- [F5]The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
- [F6]The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
- [F7]The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.
- [F8]The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
- [F9]The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
Signature
/s/ Max Sitnick, Attorney-in-fact|2026-04-20